{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T18:21:46Z","timestamp":1788373306451,"version":"build-2803163510"},"reference-count":28,"publisher":"The Journal of Rheumatology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2016,1]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>Patient participation in research is increasing; however, practical guidelines to enhance this participation are lacking. Specifically within the Outcome Measures in Rheumatology (OMERACT) organization, although patients have participated in OMERACT meetings since 2002, consensus about the procedures for involving patients in working groups has not been formalized. The objective is to develop a set of recommendations regarding patient research partner (PRP) involvement in research working groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>We conducted a systematic literature review on recommendations\/guidelines of PRP involvement in research; elaborated a structured consensus process involving multiple participants to develop a set of recommendations; and sought endorsement of recommendations by OMERACT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>In the 18 articles included in the literature review, there was general agreement on the broad concepts for recommendations covering PRP involvement in research although they were heterogeneous in detail. Most considered PRP involvement in all phases of research with early engagement, training, and support important, but details on the content were scarce. This review informed a larger consensus-building process regarding PRP inclusion in OMERACT research. Three overarching principles and 8 recommendations were developed, discussed, and refined at OMERACT 2014. The guiding principles were endorsed during the OMERACT plenary session.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>These recommendations for PRP involvement in OMERACT research reinforce the importance of patient participation throughout the research process as integral members. Although the applicability of the recommendations in other research contexts should be assessed, the generalizability is expected to be high. Future research should evaluate their implementation and their effect on outcome development.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.141011","type":"journal-article","created":{"date-parts":[[2015,4,16]],"date-time":"2015-04-16T02:11:36Z","timestamp":1429150296000},"page":"187-193","source":"Crossref","is-referenced-by-count":50,"title":["Recommendations for the Involvement of Patient Research Partners (PRP) in OMERACT Working Groups. A Report from the OMERACT 2014 Working Group on PRP"],"prefix":"10.3899","volume":"43","author":[{"given":"Peter P.","family":"Cheung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"3rd","given":"Clifton O.","family":"Bingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Kirwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amye","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyn M.","family":"March","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pam","family":"Montie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"Scholte-Voshaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Gossec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2015,4,15]]},"reference":[{"key":"2018112909351258000_43.1.187.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2005.03.012"},{"key":"2018112909351258000_43.1.187.2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-002241"},{"key":"2018112909351258000_43.1.187.3","first-page":"86","article-title":"Outcomes from the patient perspective workshop at OMERACT 6","volume":"30","author":"Kirwan","year":"2003","journal-title":"J Rheumatol"},{"key":"2018112909351258000_43.1.187.4","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.131310"},{"key":"2018112909351258000_43.1.187.5","unstructured":"Patient Centred Outcomes Research Institute (PCORI) . The power of partnership in research: improving healthcare outcomes in underserved communities. 2013. [Internet. Accessed March 3, 2015.] Available from: www.pcori.org"},{"key":"2018112909351258000_43.1.187.6","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-12-S1-A70"},{"key":"2018112909351258000_43.1.187.7","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.135129"},{"key":"2018112909351258000_43.1.187.8","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.131306"},{"key":"2018112909351258000_43.1.187.9","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.2105\/AJPH.2009.178137","article-title":"Community engagement in research: frameworks for education and peer review","volume":"10","author":"Ahmed","year":"2010","journal-title":"Am J Pub Health"},{"key":"2018112909351258000_43.1.187.10","doi-asserted-by":"publisher","DOI":"10.1093\/geront\/gnp049"},{"key":"2018112909351258000_43.1.187.11","unstructured":"Kent A . Guidance on effective involvement of patients. Draft guidelines on effective involvement (2006). Draft guideline on good practice on patient and public engagement in HTA [Internet. Accessed March 16, 2015.] Available from: www.htai.org\/index.php?id=746#c2730"},{"key":"2018112909351258000_43.1.187.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-7625.2007.00451.x"},{"key":"2018112909351258000_43.1.187.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-7625.2004.00232.x"},{"key":"2018112909351258000_43.1.187.14","unstructured":"Patient Centred Outcomes Research Institute (PCORI) . The power of partnership in research: improving healthcare outcomes in underserved communities. [Internet. Accessed March 3, 2015.] Available from: www.pcori.org\/assets\/2013\/08\/PCORI-Regional-Workshop-Memphis-Morning-Presentations-080113.pdf"},{"key":"2018112909351258000_43.1.187.15","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462311000481"},{"key":"2018112909351258000_43.1.187.16","doi-asserted-by":"publisher","DOI":"10.1177\/1049732309331869"},{"key":"2018112909351258000_43.1.187.17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1470-6431.2010.00907.x"},{"key":"2018112909351258000_43.1.187.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2012.12.010"},{"key":"2018112909351258000_43.1.187.19","doi-asserted-by":"publisher","DOI":"10.1002\/art.22091"},{"key":"2018112909351258000_43.1.187.20","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27485"},{"key":"2018112909351258000_43.1.187.21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-7625.2011.00661.x"},{"key":"2018112909351258000_43.1.187.22","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2524.2002.00376.x"},{"key":"2018112909351258000_43.1.187.23","doi-asserted-by":"publisher","DOI":"10.1046\/j.1369-6513.2003.00214.x"},{"key":"2018112909351258000_43.1.187.24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-7625.2010.00607.x"},{"key":"2018112909351258000_43.1.187.25","unstructured":"Boers M Kirwan JR Tugwell P Beaton D Bingham CO 3rd Conaghan PG The OMERACT handbook. [Internet. Accessed March 3, 2015.] Available from: www.omeract.org\/pdf\/OMERACT_Handbook.pdf"},{"key":"2018112909351258000_43.1.187.26","unstructured":"US Food Drug Administration . Guidance for clinical investigators, industry, and FDA staff. Financial disclosure by clinical investigators. [Internet. Accessed March 3, 2015.] Available from: www.fda.gov\/downloads\/RegulatoryInformation\/Guidances\/UCM341008.pdf"},{"key":"2018112909351258000_43.1.187.27","doi-asserted-by":"crossref","unstructured":"de Wit MP Elberse JE Broerse JE Abma TA . Do not forget the professional \u2014 the value of the FIRST model for guiding the structural involvement of patients in rheumatology research. Health Expect 2013 Jan 31 (E-pub ahead of print)","DOI":"10.1111\/hex.12048"},{"key":"2018112909351258000_43.1.187.28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003311"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.141011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T14:46:43Z","timestamp":1566571603000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.141011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,15]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1,1]]},"published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.3899\/jrheum.141011"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.141011","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,15]]}}}